Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (68) GO Terms (17) Nucleotides (291) Proteins (88) Interactants (382) Wiki
XB-GENEPAGE-853991

Papers associated with pou2f1



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Anti-OTF-1 antibodies inhibit NFIII stimulation of in vitro adenovirus DNA replication., Pruijn JM, van der Vliet PC, Dathan NA, Mattaj IW., Nucleic Acids Res. March 11, 1989; 17 (5): 1845-63.

Nucleotide sequence of Xenopus laevis Oct-1 cDNA., Smith DP, Old RW., Nucleic Acids Res. January 25, 1990; 18 (2): 369.

U4B snRNA gene enhancer activity requires functional octamer and SPH motifs., Zamrod Z, Stumph WE., Nucleic Acids Res. December 25, 1990; 18 (24): 7323-30.

Xenopus laevis Oct-1 does not bind to certain histone H2B gene promoter octamer motifs for which a novel octamer-binding factor has high affinity., Smith DP, Old RW., Nucleic Acids Res. February 25, 1991; 19 (4): 815-21.

Sequential expression of multiple POU proteins during amphibian early development., Hinkley CS, Martin JF, Leibham D, Perry M., Mol Cell Biol. February 1, 1992; 12 (2): 638-49.

The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity., Hentsch B, Mouzaki A, Pfeuffer I, Rungger D, Serfling E., Nucleic Acids Res. June 11, 1992; 20 (11): 2657-65.

Histone H2B gene transcription during Xenopus early development requires functional cooperation between proteins bound to the CCAAT and octamer motifs., Hinkley C, Perry M., Mol Cell Biol. October 1, 1992; 12 (10): 4400-11.

Structural requirements for the functional activity of a U1 snRNA gene enhancer., Cheung CH, Fan QN, Stumph WE., Nucleic Acids Res. January 25, 1993; 21 (2): 281-7.

Distinct elements of the xsna promoter are required for mesodermal and ectodermal expression., Mayor R, Essex LJ, Bennett MF, Sargent MG., Development. November 1, 1993; 119 (3): 661-71.                  

The promoter of the Xwnt-5C gene contains octamer and AP-2 motifs functional in Xenopus embryos., Kuiken GA, Bertens PJ, Peterson-Maduro J, Veenstra GJ, Koster JG, Destrée OH., Nucleic Acids Res. May 11, 1994; 22 (9): 1675-80.

Drug excretion mediated by a new prototype of polyspecific transporter., Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H., Nature. December 8, 1994; 372 (6506): 549-52.

Dynamic and differential Oct-1 expression during early Xenopus embryogenesis: persistence of Oct-1 protein following down-regulation of the RNA., Veenstra GJ, Beumer TL, Peterson-Maduro J, Stegeman BI, Karg HA, van der Vliet PC, Destrée OH., Mech Dev. April 1, 1995; 50 (2-3): 103-17.                            

Functional redundancy of promoter elements ensures efficient transcription of the human 7SK gene in vivo., Boyd DC, Turner PC, Watkins NJ, Gerster T, Murphy S., J Mol Biol. November 10, 1995; 253 (5): 677-90.

cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2., Okuda M, Saito H, Urakami Y, Takano M, Inui K., Biochem Biophys Res Commun. July 16, 1996; 224 (2): 500-7.

Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney., Lopez-Nieto CE, You G, Bush KT, Barros EJ, Beier DR, Nigam SK., J Biol Chem. March 7, 1997; 272 (10): 6471-8.

Expression cloning and characterization of a renal organic anion transporter from winter flounder., Wolff NA, Werner A, Burkhardt S, Burckhardt G., FEBS Lett. November 17, 1997; 417 (3): 287-91.

Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta., Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V., J Biol Chem. June 26, 1998; 273 (26): 15971-9.

Non-cell autonomous induction of apoptosis and loss of posterior structures by activation domain-specific interactions of Oct-1 in the Xenopus embryo., Veenstra GJ, Peterson-Maduro J, Mathu MT, van der Vliet PC, Destrée OH., Cell Death Differ. September 1, 1998; 5 (9): 774-84.

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain., Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V., J Biol Chem. December 4, 1998; 273 (49): 32776-86.

The Oct-1 POU domain directs developmentally regulated nuclear translocation in Xenopus embryos., Veenstra GJ, Mathu MT, Destrée OH., Biol Chem. February 1, 1999; 380 (2): 253-7.

Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes., Okuda M, Urakami Y, Saito H, Inui K., Biochim Biophys Acta. March 4, 1999; 1417 (2): 224-31.

Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain., Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H., J Biol Chem. May 7, 1999; 274 (19): 13675-80.

Maximization of selenocysteine tRNA and U6 small nuclear RNA transcriptional activation achieved by flexible utilization of a Staf zinc finger., Schaub M, Myslinski E, Krol A, Carbon P., J Biol Chem. August 27, 1999; 274 (35): 25042-50.

Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1)., Dresser MJ, Gray AT, Giacomini KM., J Pharmacol Exp Ther. March 1, 2000; 292 (3): 1146-52.

Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct., Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, Nigam SK., Am J Physiol Renal Physiol. April 1, 2000; 278 (4): F635-43.

Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus., Sweet DH, Miller DS, Pritchard JB., J Biol Chem. November 9, 2001; 276 (45): 41611-9.

Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells., Briz O, Serrano MA, Rebollo N, Hagenbuch B, Meier PJ, Koepsell H, Marin JJ., Mol Pharmacol. April 1, 2002; 61 (4): 853-60.

Renal organic cation and nucleoside transport., Chen R, Jonker JW, Nelson JA., Biochem Pharmacol. July 15, 2002; 64 (2): 185-90.

Functional characterization of mouse cation transporter mOCT2 compared with mOCT1., Kakehi M, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y., Biochem Biophys Res Commun. August 23, 2002; 296 (3): 644-50.        

The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP., Schlatter E, Mönnich V, Cetinkaya I, Mehrens T, Ciarimboli G, Hirsch JR, Popp C, Koepsell H., J Membr Biol. October 1, 2002; 189 (3): 237-44.

Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences., Kerb R, Brinkmann U, Chatskaia N, Gorbunov D, Gorboulev V, Mornhinweg E, Keil A, Eichelbaum M, Koepsell H., Pharmacogenetics. November 1, 2002; 12 (8): 591-5.

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1., Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, Ferrin TE, Herskowitz I, Giacomini KM, Pharmacogenetics Of Membrane Transporters Investigators., Proc Natl Acad Sci U S A. May 13, 2003; 100 (10): 5902-7.        

Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions., Sakata T, Anzai N, Shin HJ, Noshiro R, Hirata T, Yokoyama H, Kanai Y, Endou H., Biochem Biophys Res Commun. January 16, 2004; 313 (3): 789-93.

Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo., Belikov S, Astrand C, Holmqvist PH, Wrange O., Mol Cell Biol. April 1, 2004; 24 (7): 3036-47.

Characterization of snRNA and snRNA-type genes in the pufferfish Fugu rubripes., Myslinski E, Krol A, Carbon P., Gene. April 14, 2004; 330 149-58.

Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction., Belikov S, Holmqvist PH, Astrand C, Wrange O., J Biol Chem. November 26, 2004; 279 (48): 49857-67.

Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney., Ishiguro N, Saito A, Yokoyama K, Morikawa M, Igarashi T, Tamai I., Drug Metab Dispos. April 1, 2005; 33 (4): 495-9.

A consensus Oct1 binding site is required for the activity of the Xenopus Cdx4 promoter., Reece-Hoyes JS, Keenan ID, Pownall ME, Isaacs HV., Dev Biol. June 15, 2005; 282 (2): 509-23.              

Comparative genomics on Dkk1 orthologs., Katoh Y, Katoh M., Int J Oncol. July 1, 2005; 27 (1): 275-9.

Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium., Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H., Am J Respir Cell Mol Biol. July 1, 2005; 33 (1): 79-88.

An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling., Oren T, Torregroza I, Evans T., Nucleic Acids Res. August 1, 2005; 33 (13): 4357-67.              

Comparative genomics on SOX2 orthologs., Katoh Y, Katoh M., Oncol Rep. September 1, 2005; 14 (3): 797-800.

Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps., Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, Marin JJ., Biochem Pharmacol. September 14, 2006; 72 (6): 729-38.

Variants in the SLCO1B3 gene: interethnic distribution and association with paclitaxel pharmacokinetics., Smith NF, Marsh S, Scott-Horton TJ, Hamada A, Mielke S, Mross K, Figg WD, Verweij J, McLeod HL, Sparreboom A., Clin Pharmacol Ther. January 1, 2007; 81 (1): 76-82.

Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity., Sturm A, Gorboulev V, Gorbunov D, Keller T, Volk C, Schmitt BM, Schlachtbauer P, Ciarimboli G, Koepsell H., Am J Physiol Renal Physiol. September 1, 2007; 293 (3): F767-79.

The POU homeobox protein Oct-1 regulates radial glia formation downstream of Notch signaling., Kiyota T, Kato A, Altmann CR, Kato Y., Dev Biol. March 15, 2008; 315 (2): 579-92.      

Interaction of imatinib with human organic ion carriers., Hu S, Franke RM, Filipski KK, Hu C, Orwick SJ, de Bruijn EA, Burger H, Baker SD, Sparreboom A., Clin Cancer Res. May 15, 2008; 14 (10): 3141-8.

Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes., Song IS, Shin HJ, Shin JG., Xenobiotica. September 1, 2008; 38 (9): 1252-62.

Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status., Dai RP, Yu FX, Goh SR, Chng HW, Tan YL, Fu JL, Zheng L, Luo Y., J Biol Chem. October 3, 2008; 283 (40): 26894-901.

A microarray screen for direct targets of Zic1 identifies an aquaporin gene, aqp-3b, expressed in the neural folds., Cornish EJ, Hassan SM, Martin JD, Li S, Merzdorf CS., Dev Dyn. May 1, 2009; 238 (5): 1179-94.                

???pagination.result.page??? 1 2 ???pagination.result.next???